Sign In

Communications of the ACM

ACM TechNews

Artificial Pancreas System Controls Blood Glucose Levels Better Than Current Technology

View as: Print Mobile App Share:
The Control-IQ artificial pancreas system was derived from research done at the Center for Diabetes Technology at the University of Virginia.

A new artificial pancreas system was found to be more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.

Credit: Tandem Diabetes Care

A study funded by the U.S. National Institutes of Health detailed the clinical trial of an artificial pancreas system that automatically monitors and regulates blood glucose levels.

The Control-IQ technology is more effective than current techniques at regulating blood glucose levels in persons with type 1 diabetes throughout the day and overnight.

The closed-loop control device tracks blood glucose via a continuous glucose monitor, and automatically dispatches insulin when needed.

Control-IQ is based on a system invented at the University of Virginia, Charlottesville (UVA), with an insulin pump programmed with sophisticated control algorithms based on a mathematical model that uses glucose monitoring data to automatically adjust dosage.

UVA's Boris Kovatchev said, "There is a special safety module dedicated to prevention of hypoglycemia, and there is gradually intensified control overnight to achieve near-normal blood sugar levels every morning."

From U.S. National Institutes of Health
View Full Article


Abstracts Copyright © 2019 SmithBucklin, Washington, DC, USA


No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account